SEC Filing Summary for BIOLARGO, INC. - Form 4 Filing

This Form 4 filing details a transaction by Marshall Dennis E, a director at BIOLARGO, INC. On June 22, 2026, an option to purchase 40,909 shares of Common Stock was granted with an exercise price of $0.11. This option has an expiration date of June 22, 2036. The filing also notes the expiration of 10,000 previously held options on June 20, 2026. Following these transactions, the post-transaction shares owned are 5,463,738. The filing also includes a Limited Power of Attorney, appointing John R. Browning to handle Section 16 reporting obligations for Mr. Marshall.